Beta-casein and its complexes with chitosan as nanovehicles for delivery of a platinum anticancer drug

Colloids and Surfaces B: Biointerfaces

Volumn 112, Issue , 2013, Pages 362-367

  Razmi, Mahdieh ^a   Divsalar, Adeleh ^a,b   Saboury, Ali Akbar ^b   Izadi, Zhila ^a   Haertlé, Thomas ^c   Mansuri Torshizi, Hassan ^d  

^a KHARAZMI UNIVERSITY   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c INRA   (France)

^d UNIVERSITY OF SISTAN AND BALUCHESTAN   (Iran)

Author keywords

Beta casein; Chitosan; Nanovehicles; Oral drug delivery system; Platinum complex

Indexed keywords

AVERAGE PARTICLE SIZE; BETA-CASEIN; CHITOSAN NANOPARTICLES; DRUG-DELIVERY SYSTEMS; NANOVEHICLES; PLATINUM ANTICANCER DRUGS; PLATINUM COMPLEXES; THERMODYNAMICALLY STABLE;

CASEIN; CHITOSAN; DYNAMIC LIGHT SCATTERING; ENZYME INHIBITION; NANOPARTICLES; PH; PLATINUM COMPOUNDS; SCANNING ELECTRON MICROSCOPY;

PLATINUM;

BETA CASEIN; BIPYRIDINE MORPHOLINE DITHIOCARBAMATE PT(II) NITRATE; CHITOSAN; NANOPARTICLE; PLATINUM COMPLEX; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CARCINOMA CELL; COLORECTAL CARCINOMA; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG UPTAKE; ENCAPSULATION; HUMAN; HUMAN CELL; LIGHT SCATTERING; PARTICLE SIZE; PH; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; THERMODYNAMICS; ULTRAVIOLET SPECTROPHOTOMETRY; ZETA POTENTIAL;

BETA-CASEIN; CHITOSAN; NANOVEHICLES; ORAL DRUG-DELIVERY SYSTEM; PLATINUM COMPLEX;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; CASEINS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; COLLOIDS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HCT116 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; NANOPARTICLES; ORGANOPLATINUM COMPOUNDS;

EID: 84883807547     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.08.022     Document Type: Article

References (29)

1. Xing R., Wang X., Zhang Ch., Zhang Y., Wang Q., Yang Z., Guo Z. Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin. J. Inorg. Biochem. 2009, 103:1039-1044.
2. Jadhav V.B., Jun Y.J., Song J.H., Park M.K., Hyun Oh J., Chae S.W., Kim I., Choi S., Lee H.J., Sohn Y.S. A novel micelle-encapsulated platinum (II) anticancer agent. J. Control. Release 2010, 147:144-150.
3. Kedar U., Phutane P., Shidhaye S., Kadam V. Advances in polymeric micelles for drug delivery and tumor targeting. Nanomed. Nanotechnol. Biol. Med. 2010, 6:714-729.
4. Kumari A., Yadav S.K., Yadav S.C. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf. B 2010, 75:1-18.
5. Miyata K., Christie R.J., Kataoka K. Polymeric micelles for nano-scale drug delivery. React. Funct. Polym. 2011, 71:227-234.
6. Chen L., Remondetto G.E., Subirade M. Food protein-based materials as nutraceutical delivery systems. Trends Food Sci. Technol. 2006, 17:272-283.
7. Zimet P., Livney Y.D. Beta-lactoglobulin and its nanocomplexes with pectin as vehicles for ω-3 polyunsaturated fatty acids. Food Hydrocol. 2009, 23:1120-1126.
8. Sperber B.L.H.M., Schols H.A., Stuart M.A.C., Norde W., Voragen A.G.J. Influence of the overall charge and local charge density of pectin on the complex formation between pectin and β-lactoglobulin. Food Hydrocol. 2009, 23:765-772.
9. Ron N., Zimet P., Bargarum J., Livney Y.D. Beta-lactoglobulin-polysaccharide complexes as nanovehicles for hydrophobic nutraceuticals in non-fat foods and clear beverages. Int. Dairy J. 2010, 20:686-693.
10. Jones O., Decker E.A., McClements D.J. Thermal analysis of β-lactoglobulin complexes with pectins or carrageenan for production of stable biopolymer particles. Food Hydrocol. 2010, 24:239-248.
11. Gangnard S., Zuev Y., Gaudin J., Fedotov V., Choiset Y., Axelos M.A.V., Chobert J., Haertlé T. Modifications of the charges at the N-terminus of bovine β-casein: consequences on its structure and its micellisation. Food Hydrocol. 2007, 21:180-190.
12. Gaudin J., Parc A.L., Castrec B., Ropers M., Choiset Y., Shchutskaya J., Yousefi R., Muronetz V.I., Zuev Y., Chobert J., Haertlé T. Engineering of caseins and modulation of their structures and interactions. Biotechnol. Adv. 2009, 27:1124-1131.
13. Dickinson E., Krishna S. Aggregation in a concentrated model protein system: a mesoscopic simulation of β-casein self-assembly. Food Hydrocol. 2001, 15:107-115.
14. Caessens P.W.J.R., Jongh H.H.J.D., Norde W., Gruppen H. The adsorption-induced secondary structure of β-casein and of distinct parts of its sequence in relation to foam and emulsion properties. BBA-Protein Struct. M. 1999, 1430:73-83.
15. Shapira A., Assaraf Y.G., Livney Y.D. Beta-casein nanovehicles for oral delivery of chemotherapeutic drugs. Nanomed. Nanotechnol. Biol. Med. 2010, 6:119-126.
16. Liu Y., Guo R. pH-dependent structures and properties of casein micelles. Biophys. Chem. 2008, 136:67-73.
17. Shapira A., Assaraf Y.G., Epstein D., Livney Y.D. Beta-casein nanoparticles as an oral delivery system for chemotherapeutic drugs: impact of drug structure and properties on Co-assembly. Pharm. Res. 2010, 27:2175-2186.
18. Bachar M., Mandelbaum A., Portnaya I., Perlstein H., Even-Chen S., Barenholz Y., Danino D. Development and characterization of a novel drug nanocarrier for oral delivery, based on self-assembled β-casein micelles. J. Control. Release 2012, 160:164-171.
19. Shapira A., Markman G., Assaraf Y.G., Livney Y.D. β-casein-based nanovehicles for oral delivery of chemotherapeutic drugs: drug-protein interactions and mitoxantrone loading capacity. Nanomed. Nanotechnol. Biol. Med. 2010, 6:547-555.
20. Park J.H., Saravanakumar G., Kim K., Kwon I.C. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv. Drug Deliv. Rev. 2010, 62:28-41.
21. Trautwein E.A., Jürgensen U., Erbersdobler H.F., Cholesterol-lowering gallstone-preventing action of chitosans with different degrees of deacetylation in hamsters fed cholesterol-rich diets. Nutr. Res. 1997, 17:1053-1065.
22. Pan Y., Li Y., Zhao H., Zheng J., Xu H., Wei G., Hao J., Cui F. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int. J. Pharm. 2002, 249:139-147.
23. Chen L., Subirade M. Chitosan/β-lactoglobulin core-shell nanoparticles as nutraceutical carriers. Biomaterials 2005, 26:6041-6053.
24. Anal A.K., Tobiassen A., Flanagan J., Singh H. Preparation and characterization of nanoparticles formed by chitosan-caseinate interactions. Colloids Surf. B 2008, 64:104-110.
25. Mansouri-Torshizi H., Moghaddam M.I., Divsalar A., Saboury A.A., Diimine Platinum(II) Palladium(II) complexes of dithiocarbamate derivative as potential antitumor agents: synthesis, characterization, cytotoxicity, and detail DNA-binding studies. J. Biomol. Struct. Dyn. 2009, 26:575-586.
26. Divsalar A., Saboury A.A., Yousefi R., Moosavi-Movahedi A.A., Mansoori-Torshizi H. Spectroscopic and cytotoxic studies of the novel designed palladium(II) complexes: β-lactoglobulin and K562 as the targets. Int. J. Biol. Macromol. 2007, 40:381-386.
27. Esmaili M., Ghaffari S.M., Moosavi-Movahedi Z., Atri M.S., Sharifizadeh A., Farhadi M., Yousefi R., Chobert J., Haertlé T., Moosavi-Movahedi A.A. Beta casein-micelle as a nano vehicle for solubility enhancement of curcumin: food industry application. Food Sci. Technol.-LEB 2011, 44:2166-2172.
28. Ye A., Flanagan J., Singh H. Formation of stable nanoparticles via electrostatic complexation between sodium caseinate and gum Arabic. Biopolymers 2006, 82:121-133.
29. Paliwal R., Paliwal S.R., Agrawal G.P., Vyas S.P. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: in vitro and in vivo evaluation. Int. J. Pharm. 2012, 422:179-184.